Decoy Therapeutics (DCOY) Stock Price, Quote, News & History

Key Statistics

Open

$2.91

$2.69

Volume / Avg.

26.94K / 242.90K

Day Range

$2.69 - $2.91

52 Wk Range

2.85 - 70.80

Market Cap

$1.88M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.64%

Days to Cover

Recent Decoy Therapeutics Inc News

Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket

AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financial results for fiscal Q4 and guidance for 2027.

Avi Kapoor

Crude Oil Gains 2%; Comcast Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also

Avi Kapoor

Decoy Stock Rises After Announcing Up to $21 Million Private Placement Financing

Decoy Therapeutics shares are surging Monday after a $21 million private placement financing with a healthcare investor at $5.91 per share.

Dylan Berman

Nasdaq Jumps More Than 1%; Comcast Shares Spike Higher

US stocks higher, Nasdaq up 1%. Dow up 0.60%, Nasdaq up 1.34%, S&P 500 up 0.82%. Communication services shares jump 2.3%, materials down 1%. Comcast up 10%.

Avi Kapoor

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.32M

Investing Cash Flow (TTM)

722.31K

Financing Cash Flow (TTM)

15.10M

Free Cash Flow (TTM)

-8.94M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

7.49M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$76.30K

PE Ratio (TTM)

0.02

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.44

Earnings Yield % (TTM)

4027.08%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$6.59

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$8.29M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.91

$2.69

Volume / Avg.

26.94K / 242.90K

Day Range

$2.69 - $2.91

52 Wk Range

2.85 - 70.80

Market Cap

$1.88M

P/E Ratio

0.02

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.64%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

DCOY

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

DCOY

ABBV

FAQ

How do I buy Decoy Therapeutics (DCOY) stock?

You can purchase shares of Decoy Therapeutics (NASDAQ:DCOY) through any online brokerage.

View our list of the best stock brokerages

Who are Decoy Therapeutics (DCOY) competitors?

Other companies in Decoy Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Decoy Therapeutics (DCOY) stock?

Decoy Therapeutics has a consensus price target of $2.50.

What is the current price for Decoy Therapeutics (DCOY)?

The stock price for Decoy Therapeutics (NASDAQ: DCOY) is $2.87 last updated September 4, 2026 at 8:41 AM EDT.

Does Decoy Therapeutics (DCOY) pay a dividend?

There are no upcoming dividends for Decoy Therapeutics.

When is Decoy Therapeutics (NASDAQ:DCOY) reporting earnings?

Decoy Therapeutics does not have any upcoming earnings scheduled.

Is Decoy Therapeutics (DCOY) going to split?

There is no upcoming split for Decoy Therapeutics.

What sector and industry does Decoy Therapeutics (DCOY) operate in?

Decoy Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Decoy Therapeutics Inc (DCOY) Stock Price, Quote, News & History

Decoy Therapeutics (DCOY) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Decoy Therapeutics Inc News

Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket

Crude Oil Gains 2%; Comcast Shares Spike Higher

Decoy Stock Rises After Announcing Up to $21 Million Private Placement Financing

Nasdaq Jumps More Than 1%; Comcast Shares Spike Higher

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Financials

Cash Flows

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Decoy Therapeutics (DCOY) stock?

Who are Decoy Therapeutics (DCOY) competitors?

What is the forecast, or price target, for Decoy Therapeutics (DCOY) stock?

What is the current price for Decoy Therapeutics (DCOY)?

Does Decoy Therapeutics (DCOY) pay a dividend?

When is Decoy Therapeutics (NASDAQ:DCOY) reporting earnings?

Is Decoy Therapeutics (DCOY) going to split?

What sector and industry does Decoy Therapeutics (DCOY) operate in?